Telix Pharmaceuticals Expands North American Operations with RLS Acquisition

2 min read | September 23, 2024 09:52 AM AEST | By Team Kalkine Media

Google News:

Telix Pharmaceuticals Expands North American Operations with RLS Acquisition — Image source: shutterstock

Recent News

Santos (ASX:STO) After the Takeover Collapse: Bargain or Value Trap?

Why Pro Medicus (ASX:PME) Is Leading the Growth Stock Conversation

Is 360 (ASX:360) Amid ASX 200 Revealing Growth’s New Reality?

Why 360 (ASX:360) ASX 200 Is Facing a New Growth Test

Make Kalkine Media
My Trusted Source

Telix Pharmaceuticals Ltd (ASX:TLX), based in Melbourne, is set to significantly expand its presence in North America through the acquisition of RLS Inc., the only US radiopharmacy network accredited by the Joint Commission. This strategic move will strengthen Telix’s manufacturing and distribution capabilities across the continent, positioning it to enhance its future radiometal production network.

The acquisition agreement will see Telix take control of RLS Inc. from RLS Group Ltd. This will provide Telix access to a wide network of 31 licensed radiopharmacies located in major US cities, laying the groundwork for a robust production and distribution system. The radiopharmacies will serve to facilitate the development and last-mile delivery of key therapeutic and diagnostic isotopes in key markets.

This move also sets the stage for the extensive deployment of Telix’s proprietary ARTMS QUANTM Irradiation System™ (QIS™) cyclotron technology. This technology plays a crucial role in scaling up the production of essential isotopes used in both PET and SPECT diagnostic tracers, as well as therapeutic radiopharmaceuticals.

Telix's managing director and group CEO, Dr. Christian Behrenbruch, highlighted that the acquisition is aligned with the company's commitment to vertical integration and establishing a comprehensive, future-ready supply chain. By leveraging the ARTMS platform alongside RLS’s established network, Telix aims to secure a consistent supply of diagnostic tracers and therapeutic radiopharmaceuticals, ensuring stable delivery across the US.

This strategic investment is expected to enhance Telix's technical expertise and operational efficiency, helping to meet growing demand for its products. Additionally, the acquisition strengthens the company’s partnerships within the radiopharmacy sector, ensuring high-quality service and delivery reliability for all stakeholders involved.

With this acquisition, Telix reinforces its position as a leader in radiopharmaceuticals, bolstering its capacity to serve patients and support its partners in the evolving healthcare landscape.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.